Latest Industry Articles

Thermo Fisher wraps up $17.4 billion deal for Wilmington-based PPD

Thermo Fisher wraps up $17.4 billion deal for Wilmington-based PPD

Thermo Fisher Scientific, Inc. has completed its acquisition of Wilmington-based global contract research organization PPD. The $17.4 billion deal was finalized in December. Thermo Fisher – which supports life sciences research by helping customers solve complex analytical challenges, improve pati

Read more
New Vaxzevria Data Further Support its Use as Third Dose Booster

New Vaxzevria Data Further Support its Use as Third Dose Booster

New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha and Gamma variants following third dose booster with Vaxzevria Additional analysis showed increased antibody response to Omicron after a third dose   Positive results from a prelimina

Read more
Esaote Signs Up to the United Nations Global Compact and Consolidates its Model for Sustainability

Esaote Signs Up to the United Nations Global Compact and Consolidates its Model for Sustainability

Human rights, employment, the environment and the fight against corruption are the pillars behind the 2030 Agenda and Esaote’s commitment to positioning its business within the multidisciplinary One Health approach. Genoa, January 13th, 2022 – The Board of Directors of Esaote , a leading Ita

Read more
Pfizer CEO Says Omicron-Targeted Vaccine is Most Likely Outcome

Pfizer CEO Says Omicron-Targeted Vaccine is Most Likely Outcome

Pfizer Inc Chief Executive Albert Bourla said a redesigned COVID-19 vaccine that specifically targets the Omicron coronavirus variant is likely needed and his company could have one ready to launch by March. Bourla said Pfizer and partner BioNTech SE are working on both an Omicron-targeted

Read more
Affidea expands, Investing in Outpatient clinic in Italy,
Through acquisition of Promea SpA

Affidea expands, Investing in Outpatient clinic in Italy, Through acquisition of Promea SpA

Affidea , the largest European provider of diagnostic imaging, outpatient and cancer care services continues to invest in Italy and has today announced the 100% acquisition of Promea Center, a renowned outpatient provider in Piedmont region, Italy, specialized in o

Read more
Healthcare Transformation and Innovation takes centre stage at Arab Health

Healthcare Transformation and Innovation takes centre stage at Arab Health

For the first time, Healthcare Transformation Talks will take place on the show floor, alongside the biggest disrupters in the healthcare industry with world-renowned experts, innovators, and industry leaders discussing the latest innovations in the sector. Dubai, United Arab Emirates

Read more
Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment

Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment

PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) is authorized for emergency use in both high-risk adults and high-risk pediatric patients 12 years of age and older weighing at least 40 kg EUA based on clinical data from EPIC-HR study, showing PAXLOVID reduced risk of hosp

Read more
 EHMA announces its 2022 Annual Conference in Brussels.

EHMA announces its 2022 Annual Conference in Brussels.

Healthcare Systems at a Crossroads: What’s Next from Here?  EHMA 2022 is the 27th Annual Conference of the European Health Management Association taking place in conjunction with the association’s 40th anniversary. It will bring together key healthcare stakeholders in Brussels providing

Read more
Siemens Healthineers Accelerating Growth & Launching “New Ambition” – Third Phase of Strategy 2025

Siemens Healthineers Accelerating Growth & Launching “New Ambition” – Third Phase of Strategy 2025

Second strategy phase “Upgrading” completed one year ahead of schedule New Ambition addresses the greatest opportunities in healthcare: fighting the most threatening diseases, enabling efficient operations, expanding access to care Comparable revenue growth of 6 to 8 percent p.a. and adjusted EP

Read more
Affidea expands in Italy, Lombardy region, With acquisition of two new Outpatient Medical Centers

Affidea expands in Italy, Lombardy region, With acquisition of two new Outpatient Medical Centers

Affidea , the largest European provider of diagnostic imaging, outpatient and cancer care services   continues to invest in the Italian market and has today announced the 100% acquisition of Medical Sport Center and Medical Center, two flagship medical centers in   Lod

Read more

Highlighted Products